Tekla Life Sciences Investors (NYSE:HQL)

18.50
Delayed Data
As of Dec 06
 -0.22 / -1.18%
Today’s Change
18.30
Today|||52-Week Range
22.70
-6.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

--
Revenue and IncomeInterest Income1.4M1.7M2.0M--
 
 
 
 
Net Revenues6.3M47.0M36.0M--
 
 
 
 
Cost of Goods Sold4.9M5.1M5.2M--
 
 
 
 
 
Operating ExpensesGross Income1.3M41.8M30.8M--
 
 
 
 
General Expenses279.2K420.0K376.7K--
 
 
 
 
Other Operating Expenses13.0M-27.1M1.7M--
 
 
 
 
Total Operating Expenses18.2M-21.6M7.3M--
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.9M68.6M28.7M--
 
 
 
 
Other Expenses-2.4K0.00-3.6K--
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.9M68.6M28.7M--
 
 
 
 
Net Income-11.9M68.6M28.7M--
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS20.7M21.4M22.4M--
 
 
 
 
Shares To Calculate EPS Diluted20.7M21.4M22.4M--
 
 
 
 
 
Earnings Per ShareEPS-$0.57$3.21$1.28--
 
 
 
 
EPS Diluted-$0.57$3.21$1.28--